Expression of Bcl-2 in feline lymphoma cell lines

Veterinary Clinical Pathology

Volumn 37, Issue 1, 2008, Pages 57-60

  Kano, Rui ^a   Sato, Eimi ^a   Okamura, Tomotaka ^a   Watanabe, Shinichi ^b   Hasegawa, Atsuhiko ^a  

^a NIHON UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Anti apoptosis; Bcl 2; Cell line; Feline; Immunoblot assay; Lymphoma

Indexed keywords

PROTEIN BCL 2;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; GENE EXPRESSION REGULATION; GENETICS; LYMPHOMA; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CATS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPHOMA; PROTO-ONCOGENE PROTEINS C-BCL-2;

ESCHERICHIA COLI; FELIDAE;

EID: 44449113189     PISSN: 02756382     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2008.00013.x     Document Type: Article

References (15)

1. Kerr JF, Winterford CM, Harmon V. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 1994;73:2013-2026.
2. Meterissian SH. Apoptosis: its role in the progression of and chemotherapy for carcinoma. J Am Coll Surg. 1997;18:658-666.
3. Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 1986;47:19-28.
4. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA. 1986;83:5214-5218.
5. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood. 1993;81:151-157.
6. Huang Z. Bcl-2 family proteins as targets for anticancer drug design. Oncogene. 2000;19:6627-6631.
7. Bargou RC, Daniel PT, Mapara MY, et al. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer. 1995;60:854-859.
8. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res. 1996;56:2422-2427.
9. Sano J, Nagafuchi S, Yamazaki J, Oguma K, Kano R, Hasegawa A. Effect of antineoplastic drugs on the expression of Bcl-2 and Bcl-xL genes in the feline T-cell leukemia cell line. Res Vet Sci. 2005;79:197-201.
10. Yamazaki J, Hasebe N, Nagafuchi S, et al. Expression of apoptosis-related gene mrnas in feline T-cells infected with feline immunodeficiency virus (FIV). Vet Microbiol. 2004;101:1-8.
11. Madewell BR, Candour-Edwards R, Edwards BF, Walls JE, Griffey SM. Topographic distribution of bcl-2 protein in feline tissues in health and neoplasia. Vet Pathol. 1999;36:565-573.
12. Dank G, Lucroy MD, Griffey SM, Candour-Edwards R, Madewell BR. Bcl-2 and MIB-1 labeling indexes in cats with lymphoma. J Vet Intern Med. 2002;16:720-725.
13. Miura T, Tsujimoto H, Fukasawa M, et al. Structural abnormality and over-expression of the myc gene in feline leukemias. Int J Cancer. 1987;40:564-569.
14. Miura T, Shibuya M, Tsujimoto H, Fukasawa M, Hayami M. Molecular cloning of a feline leukemia provirus integrated adjacent to the c-myc gene in a feline T-cell leukemia cell line and the unique structure of its long terminal repeat. Virology. 1989;169:458-461.
15. Nelson RW, Couto CG. Small Animal Internal Medicine. 2nd ed. St. Louis, MO: Mosby; 1998:1123-1133.